(Q43034053)

12 November 2017

title

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

12 November 2017

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1

Elisabetta Bugianesi

1 reference

12 November 2017

6

Mario Rizzetto

1 reference

12 November 2017

Gulio Marchesini

2

1 reference

12 November 2017

Elena Gentilcore

3

1 reference

12 November 2017

Ian Homer Y Cua

4

1 reference

12 November 2017

Ester Vanni

5

1 reference

12 November 2017

Jacob George

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

12 November 2017

1 reference

12 November 2017

volume

44

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

1648-1655

1 reference

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

12 November 2017

cites work

1 reference

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

21 January 2018

1 reference

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

7 January 2021

The metabolic syndrome

1 reference

7 January 2021

Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always

1 reference

7 January 2021

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

1 reference

7 January 2021

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

1 reference

7 January 2021

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

7 January 2021

Expression of liver steatosis in hepatitis C virus infection and pattern of response to alpha-interferon

1 reference

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

7 January 2021

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

1 reference

7 January 2021

Histopathological aspects of viral hepatitis

1 reference

7 January 2021

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1 reference

7 January 2021

Steatosis: co-factor in other liver diseases.

1 reference

7 January 2021

An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation

1 reference

7 January 2021

Steatosis and intrahepatic hepatitis C virus in chronic hepatitis

1 reference

7 January 2021

Hepatic steatosis and insulin resistance: does etiology make a difference?

1 reference

7 January 2021

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

1 reference

7 January 2021

Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis

1 reference

7 January 2021

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease

1 reference

7 January 2021

Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

1 reference

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

7 January 2021

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

1 reference

7 January 2021

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

1 reference

7 January 2021

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

7 January 2021

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

7 January 2021

Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.

1 reference

7 January 2021

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

7 January 2021

Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways

1 reference

7 January 2021

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

7 January 2021

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

7 January 2021

Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21429

1 reference

12 November 2017

1 reference